Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates
Dr. London is a global leader in veterinary targeted therapies. She discusses potential risks to veterinary staff, the value of targeted therapy in times of constrained PPE resources, and the effects of COVID-19 on research activity.
Why is the Palladia dose used at the clinic often different from the one on the FDA-approved label? Over 100 human targeted therapies have been approved, yet many doses were found to be incorrect in the post market stage. Why is that?Data
Dr. Mason shares insight from the groundbreaking work her team is doing with hemangiosarcoma genetics and discussses the findings from her research on immunology and its influence on the future of veterinary medicine.Webinars
Dr. Rod Page and Dr. Kelly Diehl discuss the origins of the Golden Retriever Lifetime Study, the data trends, and its impact on veterinary medicine.Webinars
FidoCure® stands in solidarity with Black Lives Matter. All businesses, and especially mission driven businesses like ours, must fight abuse of power and social injustice.
In human oncology, there has been a growing focus on analyzing data gathered from routine care, leading to a new field called real world evidence (RWE), which has taken off in recent years. The RWE approaches being used in human oncology can also be applied in the veterinary space.
Telemedicine in veterinary care experienced a boom with the COVID-19 pandemic. As the world shifts to a new normal, Dr. Apryle Horbal joins us to examine the path ahead for telemedicine in veterinary care.Webinars
Telemedicine in veterinary care experienced a boom with the COVID-19 pandemic. Dr. Lance M. Roasa joins us to examine the path ahead for telemedicine in veterinary care.Webinars
Dr. Carrie Jurney highlights the history of mental health in the veterinary community and delves into its effects during the global pandemic.Webinars